Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010

Eurosurveillance

Volumn 16, Issue 6, 2011, Pages

  Unemo, M ^a   Golparian, D ^a   Hestner, A ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b Department of Dermatology and Venereology ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CEPHALOSPORIN C;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE REPORT; DRUG TREATMENT FAILURE; DYSURIA; GONORRHEA; HETEROSEXUAL MALE; HUMAN; MALE; NEISSERIA GONORRHOEAE; ORAL SEXUAL CONTACT; PHARYNGEAL GONORRHEA; PHARYNX DISEASE; POLYMERASE CHAIN REACTION; SEXUAL INTERCOURSE; SWEDEN; URETHRA DISEASE; UROGENITAL TRACT INFECTION;

EID: 79951640425     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Unemo M, Sjöstrand A, Akhras M, Gharizadeh B, Lindbäck E, Pourmand N, et al. Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain. APMIS. 2007;115(3):231-41.
2. European Committee on Antimicrobial Susceptibility Testing (EUCAST). European Society of Clinical Microbiology and Infectious Diseases. Clinical breakpoints. EUCAST. [Accessed 8 Feb 2011]. Available from: http://www.eucast.org/clinical_breakpoints/
3. Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother. 2009;63(6):1142-51.
4. Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug- and extensively drugresistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7(7):821-34.
5. Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, et al. Threat to cefixime treatment of gonorrhea. Emerg Infect Dis. 2007;13(8):1275-7.
6. Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 2010;15(47):pii=19721.Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19721
7. Lindberg R, Fredlund H, Nicholas R, Unemo M. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: Association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother. 2007;51(6):2117-22.
8. Zhao S, Duncan M, Tomberg J, Davies C, Unemo M, Nicholas R. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2009;53(9):3744-51.
9. Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol. 2009;58(Pt 5):683-7.
10. Moran JS. Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Sex Transm Dis. 1995;22(1):39-47.
11. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis. 2007;44(Suppl 3):S84-101.
12. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148(8):606-13.
13. Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011;17(1):148-9.
14. Neisseria gonorrhoeae Multi Antigen Sequence Typing (NGMAST). London: Imperial College London. [Accessed 8 Feb 2011]. Available from: http://www.ng-mast.net/
15. Chisholm SA, Mouton JW, Lewis DA, Nichols T, Ison CA, Livermore DM. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother. 2010;65(10):2141-8.
16. Sathia L, Ellis B, Phillip S, Winston A, Smith A. Pharyngeal gonorrhoea - is dual treatment the way forward? Int J STD AIDS. 2007;18(9):647-8.